Praxis Precision Medicines, Inc.
PRAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $903 | $797 | $1,538 |
| - Cash | $150 | $157 | $166 | $215 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | – | $746 | $633 | $1,324 |
| Revenue | $0 | $0 | $0 | $7 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$66 | -$63 | -$61 | -$49 |
| % Margin | – | – | – | -654.2% |
| EBITDA | -$74 | -$76 | -$75 | -$64 |
| % Margin | – | – | – | -856.3% |
| Net Income | -$74 | -$71 | -$69 | -$59 |
| % Margin | – | – | – | -786.3% |
| EPS Diluted | -3.36 | -3.31 | -3.29 | -2.94 |
| % Growth | -1.5% | -0.6% | -11.9% | – |
| Operating Cash Flow | -$65 | -$55 | -$53 | -$56 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$65 | -$55 | -$53 | -$56 |